Get the latest news, insights, and market updates on CNTB (Connect Biopharma Holdings Limited). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26th, 2026 at 2:40 p.m. ET. The live webcast of the presentation may be accessed via the Invest Feb 19, 2026 - $CNTB
3 Promising Penny Stocks With Market Caps Up To $400M
Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase... Jan 21, 2026 - $CNTB
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
– Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart – – Recruitment ongoing for Phase 1b study of intravenously-administered rademikibart designed to further confirm its unique ability to rapidly improve airway function with topline results expected in first quarter 2026 – – Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in mid-202 Jan 12, 2026 - $CNTB
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks
As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Penny stocks, though often considered a relic of past market trends, remain a compelling option for those seeking growth potential at lower price points. These stocks typically represent smaller or newer companies and can offer significant upside when backed by strong financial health and solid... Dec 23, 2025 - $CNTB
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2nd, 2025 at 10:50 a.m. ET. The live webcast of the presentation may be accessed via the In Nov 24, 2025 - $CNTB
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
– Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 – – New Drug Application for rademikibart for the treatment of atopic dermatitis submitted by Simcere, the Company’s exclusive licensee in Greater China, was accepted by China’s NMPA – – Completed termination of American Depositary Receipt program and directly listed our ordinary shares on Nasdaq – – Presented positive data at ERS 2025 suppo Nov 12, 2025 - $CNTB
Relmada Therapeutics Leads These 3 Promising Penny Stocks
On November 4, 2025, major U.S. stock indexes closed sharply lower, with tech stocks leading the decline and Bitcoin experiencing a notable drop. In such volatile market conditions, investors often seek out opportunities that might offer both affordability and growth potential. Penny stocks, though sometimes seen as relics of past market eras, continue to represent viable investment areas for those willing to explore smaller or newer companies with strong financial foundations. Nov 5, 2025 - $CNTB
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused ... Oct 30, 2025 - $CNTB
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple